| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 617.73B | 606.79B | 563.55B | 579.23B | 553.83B | 533.87B |
| Gross Profit | 74.97B | 73.66B | 61.99B | 63.71B | 58.12B | 54.75B |
| EBITDA | 51.96B | 65.94B | 56.83B | 58.55B | 53.49B | 54.03B |
| Net Income | 31.39B | 30.75B | 24.38B | 24.96B | 22.64B | 23.54B |
Balance Sheet | ||||||
| Total Assets | 546.13B | 545.19B | 505.05B | 481.66B | 462.47B | 456.83B |
| Cash, Cash Equivalents and Short-Term Investments | 44.47B | 48.60B | 52.13B | 52.67B | 43.62B | 37.68B |
| Total Debt | 111.03B | 89.50B | 79.79B | 56.16B | 53.55B | 55.43B |
| Total Liabilities | 256.71B | 248.12B | 219.61B | 209.12B | 213.74B | 219.79B |
| Stockholders Equity | 285.75B | 293.21B | 282.05B | 269.29B | 245.96B | 234.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 22.07B | 8.63B | 18.80B | 29.93B | 8.81B |
| Operating Cash Flow | 0.00 | 43.53B | 21.73B | 33.28B | 43.69B | 25.04B |
| Investing Cash Flow | 0.00 | -26.47B | -18.43B | -16.53B | -14.94B | -15.30B |
| Financing Cash Flow | 0.00 | -25.31B | -9.14B | -11.11B | -24.49B | -7.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥512.84B | 17.00 | 7.52% | 3.35% | 6.71% | 15.51% | |
74 Outperform | ¥397.36B | 10.72 | 11.08% | 2.55% | 6.45% | 24.72% | |
68 Neutral | ¥951.29B | 10.15 | 9.97% | 3.54% | 12.46% | -3.12% | |
68 Neutral | ¥496.38B | 11.01 | 13.93% | 2.81% | 8.22% | 48.07% | |
66 Neutral | ¥304.51B | 12.68 | 8.30% | 2.50% | 7.94% | -13.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | ¥866.10B | 310.63 | ― | 2.99% | 4.96% | 1.67% |